FDA cleared Beta Bionics’ Mint patch pump. Why did BBNX immediately sell $150m of stock?
Beta Bionics wins FDA clearance for Mint, targets a Q1 2027 launch and prices a $150 million offering to support commercialization.
Medical Devices & Diagnostics